Abstract—The concept of nootropics was introduced into pharmacology in the early 1970s by Corneliu Giurgea, a Belgian pharmacologist of Romanian origin, based on the study of 2-oxo-1-pyrrolidine derivatives, which later became known as racetams. This paper substantiates the idea that the emergence of modern ideas about nootropics and similar compounds (psychoenergizers, antihypoxants, and actoprotectors) in a certain sense was preceded by the concept of adaptogens by N.V. Lazarev (1953–1958), whose theoretical development went towards concretization of certain provisions of this concept. The formation of the problem of nootropics, their place in modern pharmacology, the origins and prospects for the development of the concept, and the search for new pharmacological agents with nootropic properties are considered. Nootropic activity is analyzed from the standpoint of the mechanisms of action of racetams, neuropeptides, GABA derivatives, and benzimidadols.
This is a preview of subscription content, log in via an institution to check access.
REFERENCES
Brekhman, I.I., Eleuterokokk (Eleutherococcus), Leningrad: Nauka, 1968.
Bobkov, Yu.G., Vinogradov, V.M., Katkov, V.F., Losev, S.S., and Smirnov, A.V., Farmakologicheskaya korrektsiya utomleniya (Pharmacological Correction of Exhaustion), L.: Meditsina, 1984. 208 s.
Vinogradov, V.M. and Krivoruchko, B.I., Psikhofarmakol. i Biol. Narkol., 2001, vol. 1, no. 1, pp. 27–37.
Grechko, A.T., Mezhdunar. Med. Obzory, 1994, vol. 2, no. 5, pp. 330–333.
Glushchenko, V.V. and Shabanov, P.D., Minimal’naya disfunktsiya mozga (Minimal Brain Dysfunction), Moscow: Binom, 2013.
Giurgea, C.E., Actuel. Pharmacol. (Paris), 1972, vol. 25, pp. 115—156.
Kupalov, P.S., Mekhanizmy zamykaniya vremennoi svyazi v norme i patologii (Mechanisms of Closing Temporal Connections in Norm and Pathology), Moscow: Nauka, 1978.
Giurgea, C.E., Pavlov J. Biol. Sci., 1989, vol. 24, no. 3, pp. 81–89.
Giurgea, C.E., Extended Abstract of Cand. Sci. Dissertation, Leningrad Medical Institute imeni Akademika I.P. Pavlova, Leningrad, 1952.
Giurgea, C., Cond. Reflex, 1973, vol. 8, no. 2, pp. 108–115.
Giurgea, C.E., Greindl, M.G., and Preat, S., Acta Psychiatr. Belg., 1983, vol. 83, no. 4, pp. 349–358.
Shabanov, P.D. and Borodkin, Yu.S., Narusheniya pamyati i ikh korrektsiya (Disruptions of Memory and Their Correction), Leningrad: Nauka, 1989.
Kovalev, G.V., Nootropnye sredstva (Nootropic Drugs), Volgograd: Srednevolzhskoe Izd., 1990.
Mashkovskii, M.D., Lekarstvennye sredstva (Medicines), Moscow: Novaya Volna, 2002, vol. 1, pp. 133—136.
Voronina, T.A., Psikhofarmakol. i Biol. Narkol., 2002, vol. 2, nos. 3–4, pp. 375–378.
Arushanyan, E.B., Lekarstva, uluchshayushchie poznavatel’nuyu deyatel’nost’ mozga (nootropnye sredstva) (Drugs Improving Cognitive Activity of the Brain (Nootropic Drugs), Stavropol’: Izd. StGMA, 2004.
Shabanov, P.D., Psikhofarmakologiya (Psychopharmacology), St. Petersburg: N-L, 2008.
Shabanov, P.D., Narkologiya. Izdanie vtoroe (Narcology. Second Edition), Moscow: Geotar-Media, 2012.
Shabanov, P.D., Kontseptsiya adaptogens: istoki, sovremennoe sostoyanie, perspektivy. Akt. rech’ na Vtorykh Lazarevskikh chteniyakh (Concept of Adaptogens: Origins, Current State, and Perspectives. Commencement Address at Lazarev Readings), St. Petersburg: VMedA, 2002.
Funding
There is no external funding.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interests. The author declares that he has no conflicts of interest.
Additional information
Corresponding author; address: ul. Acad. Lebedeva 6, St. Petersburg, 194044 Russia; e-mail: pdshabanov@mail.ru.
Rights and permissions
About this article
Cite this article
Shabanov, P.D. The Origins and Background of the Creation of the Nootropics Concept. Neurochem. J. 17, 163–168 (2023). https://doi.org/10.1134/S1819712423020125
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1819712423020125